Answers are grounded in this paper and cite their sources.
Metallo β -lactamases (MBLs) producing Pseudomonas aeruginosa have been detected from clinical isolates in worldwide with increase in emergence in the last years .The spread of MBLs positive isolates in a localized hospital environment causes not only a therapeutic problem but as well as a serious concern for infection control handling , hence , this study was aimed to determine the prevalence of P. aeruginosa producing MBLs isolated from some skin infections (wounds and burns).A total of 57 P. aeruginosa were isolated from wounds and burns infections (24 wound swabs and 33 burn swabs) in Al-Hussain Teaching Hospital .Primary screening of carbapenems resistant isolates appeared that 63% (36 isolates) were resistant to imipenem and meropenem .Among the 36 carbapenems resistant isolates that were tested for production MBLs by phenotypic test (CDT)with EDTA inhibitor (as chelating factor ), 34 (94%) were MBLs positive and 59.6% from 57 isolates were positive to MBLs production .MICs values of MBLs producers were higher in imipenem ((≥16-64) μg/ml)) than that in meropenem (( ≥16-32) μg/ml)) .Out of 34 MBLs producer , 24 (72.7%)isolates were founded in specimens of burn swabs , while the wound swabs specimens registered 41.6% .MBLs producing isolates were also tested for antibiotics susceptibility , all isolates (100%)were sensitive to aztreonam and 70.5% to ciprofloxacin .100% of isolates were resistant to cefoxitin and amoxycillinclavulanic acid.
No takes yet. Share an insight, caveat, or question.
A 2019 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: